Related Experiment Videos

MR observations on the effects of praziquantel in neurocysticercosis

A Jena1, P C Sanchetee, R Tripathi

  • 1NMR Research Centre, Institute of Nuclear Medicine and Allied Sciences, Delhi, India.

Insights

Praziquantel (PZQ) treatment for neurocysticercosis causes early cyst enlargement and edema, followed by parasite degeneration. Magnetic resonance imaging (MRI) effectively tracks these drug effects on brain lesions.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Radiology

Background:

  • Neurocysticercosis is a significant cause of epilepsy and neurological disorders globally.
  • Praziquantel (PZQ) is a primary anthelmintic drug used for treating neurocysticercosis.

Purpose of the Study:

  • To investigate the early effects of praziquantel on neurocysticercosis brain lesions.
  • To evaluate the utility of serial magnetic resonance (MR) imaging in monitoring treatment response.

Main Methods:

  • Serial MR imaging was performed on eight patients with neurocysticercosis undergoing PZQ treatment.
  • Imaging focused on changes in cyst size, pericystic edema, and parasite (scolex) degeneration.

Main Results:

  • Early increases in cyst size and pericystic edema were observed within 24 hours of PZQ administration.
  • Gradual degeneration of the scolex and cyst contents was documented over time.
  • Individual cyst responses and disappearance rates varied significantly.

Conclusions:

  • MR imaging is a sensitive tool for objectively documenting early changes in neurocysticercosis lesions following PZQ treatment.
  • Serial MRI can visualize the dynamic response patterns of brain cysticercosis to cysticidal drugs.

Related Concept Videos